Copyright
©The Author(s) 2020.
World J Gastroenterol. Dec 14, 2020; 26(46): 7382-7404
Published online Dec 14, 2020. doi: 10.3748/wjg.v26.i46.7382
Published online Dec 14, 2020. doi: 10.3748/wjg.v26.i46.7382
Characteristics | Preoperative plasma fibrinogen concentration | P value | |
> 3.31 g/L, n = 141 | ≤ 3.31 g/L, n = 141 | ||
Age in yr | 0.812 | ||
> 60 | 72 (25.5) | 74 (26.2) | |
≤ 60 | 69 (24.5) | 67 (23.8) | |
Sex | 0.283 | ||
Male | 71 (25.2) | 80 (28.4) | |
Female | 70 (24.8) | 61 (21.6) | |
Clinical symptoms | < 0.001 | ||
Absent | 15 (5.3) | 42 (14.9) | |
Present | 126 (44.7) | 99 (35.1) | |
Diabetes | 0.357 | ||
Absent | 97 (34.4) | 104 (36.9) | |
Present | 44 (15.6) | 37 (13.1) | |
Smoking status | 0.889 | ||
Absent | 107 (37.9) | 108 (38.3) | |
Present | 34 (12.1) | 33 (11.7) | |
Alcohol consumption | 0.263 | ||
Absent | 121 (42.9) | 114 (40.4) | |
Present | 20 (7.1) | 27 (9.6) | |
Family history of cancer | 0.356 | ||
Absent | 137 (48.6) | 134 (47.5) | |
Present | 4 (1.4) | 7 (2.5) | |
Blood type | 0.565 | ||
A | 39 (13.8) | 48 (17.0) | |
B | 51 (18.1) | 42 (14.9) | |
AB | 10 (3.5) | 12 (4.3) | |
O | 41 (14.5) | 39 (13.8) | |
Tumor location | < 0.001 | ||
Head and neck | 80 (28.4) | 50 (17.7) | |
Body and tail | 61 (21.6) | 91 (32.3) | |
Approaches of open surgery | < 0.001 | ||
Pancreaticoduodenectomy | 80 (28.4) | 50 (17.7) | |
Distal pancreatectomy with splenectomy | 61 (21.6) | 91 (32.3) | |
Degree of differentiation | 0.079 | ||
Well | 20 (7.1) | 14 (5.0) | |
Moderately | 111 (39.4) | 106 (37.6) | |
Poorly | 10 (3.5) | 21 (7.4) | |
Lymphovascular invasion | 0.233 | ||
Absent | 97 (34.4) | 106 (37.6) | |
Present | 44 (15.6) | 35 (12.4) | |
Perineural invasion | 0.054 | ||
Absent | 28 (9.9) | 42 (14.9) | |
Present | 113 (40.1) | 99 (35.1) | |
Capsular invasion | 0.271 | ||
Absent | 21 (7.4) | 28 (9.9) | |
Present | 120 (42.6) | 113 (40.1) | |
Maximum tumor diameter in cm | 1.000 | ||
> 4 | 44 (15.6) | 44 (15.6) | |
≤ 4 | 97 (34.4) | 97 (34.4) | |
T stage | 0.991 | ||
T1 | 17 (6.0) | 17 (6.0) | |
T2 | 80 (28.4) | 79 (28.0) | |
T3 | 44 (15.6) | 45 (16.0) | |
Number of metastatic lymph nodes | 0.718 | ||
Absent | 82 (29.1) | 79 (28.0) | |
Present | 59 (20.9) | 62 (22.0) | |
N stage | 0.110 | ||
N0 | 82 (29.1) | 79 (28.0) | |
N1 | 40 (14.2) | 52 (18.4) | |
N2 | 19 (6.7) | 10 (3.5) | |
TNM stage | 0.099 | ||
IA | 8 (2.8) | 12 (4.3) | |
IB | 44 (15.6) | 48 (17.0) | |
IIA | 30 (10.6) | 19 (6.7) | |
IIB | 40 (14.2) | 52 (18.4) | |
III | 19 (6.7) | 10 (3.5) | |
Adjuvant therapy | 0.631 | ||
Absent | 64 (22.7) | 60 (21.3) | |
Present | 77 (27.3) | 81 (28.7) | |
Preoperative CA19-9 level in U/mL | 0.023 | ||
> 336.4 | 47 (16.7) | 30 (10.6) | |
≤ 336.4 | 94 (33.3) | 111 (39.4) | |
Preoperative plasma albumin level in g/L | 0.006 | ||
> 45.2 | 32 (11.3) | 53 (18.8) | |
≤ 45.2 | 109 (38.2) | 88 (31.2) | |
Preoperative FAR | < 0.001 | ||
> 0.08 | 114 (40.4) | 12 (4.3) | |
≤ 0.08 | 27 (9.6) | 129 (45.7) |
- Citation: Zhang LP, Ren H, Du YX, Wang CF. Prognostic value of the preoperative fibrinogen-to-albumin ratio in pancreatic ductal adenocarcinoma patients undergoing R0 resection. World J Gastroenterol 2020; 26(46): 7382-7404
- URL: https://www.wjgnet.com/1007-9327/full/v26/i46/7382.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i46.7382